PASSAGE BIO, INC. Stock Issued During Period, Shares, Reverse Stock Splits
PASSAGE BIO, INC. (PASG) had Stock Issued During Period, Shares, Reverse Stock Splits of 0 shares as of 2025-07-14, per its S-4/A filed 2026-09-03.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2026-09-03
- 2025-07-14: Stock Issued During Period, Shares, Reverse Stock Splits 0.00 shares.
- 2025-06-26: Stock Issued During Period, Shares, Reverse Stock Splits 0.00 shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|
| 2025-07-14 | 0.00 shares S-4/A · filed 2026-09-03 |
| 2025-06-26 | 0.00 shares 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |